FRANKLYN G PRENDERGAST
CIK 1233256 · last filed 2023-10-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$78.81M
Companies
5
Total Filings
27
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMNM | Director | 60,840 | $18.38 | $1.12M | $0 | 4 | 2023-10-04 |
| NeuBase Therapeutics, Inc. (NBSE) Delisted | Director | — | $0.38 | — | $0 | 4 | 2022-09-12 |
| LTRN | Director | — | $3.88 | — | $0 | 2 | 2021-11-08 |
| Vyant Bio, Inc. (CGIX) Delisted | Director | 12,500 | $4.61 | $57.6K | $0 | 6 | 2019-08-21 |
| LLY | Director | 68,574 | $1133.00 | $77.69M | $0 | 11 | 2017-11-22 |
Recent Filings · Page 2 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-16 | NeuBase Therapeutics, Inc. (NBSE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-22 | LLY | Grant (A) | +802 | $66.7K | EDGAR |
| 2017-10-02 | Vyant Bio, Inc. (CGIX) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2017-06-08 | Vyant Bio, Inc. (CGIX) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2016-12-01 | LLY | Grant (A) | +2,088 | $160.0K | EDGAR |
| 2016-10-13 | Vyant Bio, Inc. (CGIX) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2015-12-02 | LLY | Grant (A) | +1,785 | $145.0K | EDGAR |
| 2015-05-18 | Vyant Bio, Inc. (CGIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-02 | LLY | Grant (A) | +2,155 | $145.0K | EDGAR |
| 2013-12-03 | LLY | Grant (A) | +2,841 | $145.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.